Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1

被引:61
作者
Beaulieu, Lea M.
Church, Frank C.
机构
[1] Univ N Carolina, Dept Pathol & Lab Med, Sch Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med, Sch Med, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA
关键词
activated protein C; EPCR; PAR-1; migration; transwell invasion and chemotaxis assay; Na butyrate; hirudin;
D O I
10.1016/j.yexcr.2006.11.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Activated protein C (APC) is a serine protease that regulates thrombin (IIa) production through inactivation of blood coagulation factors Va and VIIIa. APC also has non-hemostatic functions related to inflammation, proliferation, and apoptosis through various mechanisms. Using two breast cancer cell lines, MDA-MB-231 and MDA-MB-435, we investigated the role of APC in cell chemotaxis and invasion. Treatment of cells with increasing APC concentrations (1-50 mu g,/ml) increased invasion and chemotaxis in a concentration-dependent manner. only the active form of APC increased invasion and chemotaxis of the MDA-MB-231 cells when compared to 3 inactive APC derivatives. Using a modified "checkerboard" analysis, APC was shown to only affect migration when plated with the cells; therefore, APC is not a chemoattractant. Blocking antibodies to endothelial protein C receptor (EPCR) and protease-activated receptor-1 (PAR-1) attenuated the effects of APC on chemotaxis in the MDA-MB-231 cells. Finally, treatment of the MDA-MB-231 cells with the proliferation inhibitor, Na butyrate, showed that APC did not increase migration by increasing cell number. Therefore, APC increases invasion and chemotaxis of cells by binding to the cell surface and activating specific signaling pathways through EPCR and PAR-1. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:677 / 687
页数:11
相关论文
共 52 条
[1]
Regulation of human colonic cell line proliferation and phenotype by sodium butyrate [J].
Basson, MD ;
Turowski, GA ;
Rashid, Z ;
Hong, F ;
Madri, JA .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (10) :1986-1993
[2]
Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[3]
Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion [J].
Booden, MA ;
Eckert, LB ;
Der, CJ ;
Trejo, J .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (05) :1990-1999
[4]
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective [J].
Cheng, T ;
Liu, D ;
Griffin, JH ;
Fernández, JA ;
Castellino, F ;
Rosen, ED ;
Fukudome, K ;
Zlokovic, BV .
NATURE MEDICINE, 2003, 9 (03) :338-342
[5]
Davis T, 2000, CLIN CANCER RES, V6, P4334
[6]
Urokinase induces basophil chemotaxis through a urokinase receptor or epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2 [J].
de Paulis, A ;
Montuori, N ;
Prevete, N ;
Fiorentino, I ;
Rossi, FW ;
Visconte, V ;
Rossi, G ;
Marone, G ;
Ragno, P .
JOURNAL OF IMMUNOLOGY, 2004, 173 (09) :5739-5748
[7]
Protein C pathway in sepsis [J].
Esmon, CT .
ANNALS OF MEDICINE, 2002, 34 (7-8) :598-605
[8]
The protein C pathway [J].
Esmon, CT .
CHEST, 2003, 124 (03) :26S-32S
[9]
ESMON CT, 1976, J BIOL CHEM, V251, P3052
[10]
Endothelial protein C receptor-dependent inhibition of migration of human lymphocytes by protein C involves epidermal growth factor receptor [J].
Feistritzer, C ;
Mosheimer, BA ;
Sturn, DH ;
Riewald, M ;
Patsch, JR ;
Wiedermann, CJ .
JOURNAL OF IMMUNOLOGY, 2006, 176 (02) :1019-1025